Maine
For Maine, price increase % trigger is insulin-specific: manufacturers must report WAC per pricing unit for each category of insulin; implementing agency is Maine Health Data Organization; statute is S.P. 996, verified against its source on 2026-11-15.
- State
- Maine our reading
- Price increase % trigger
- insulin-specific: manufacturers must report WAC per pricing unit for each category of insulin
- Implementing agency
- Maine Health Data Organization verified
- Statute
- S.P. 996 verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Cite as: Maine — State drug price transparency reporting thresholds, triggers, and penalties for pharmaceutical manufacturers (State drug price transparency reporting thresholds, triggers, and penalties for pharmaceutical manufacturers), referencesource.org/drug-price-transparency-thresholds/maine/, checked 2026-11-15.
What the source says
S.P. 996 now requires manufacturers of insulin to notify the Maine Health Data Organization of the WAC per pricing unit for insulin produced by the manufacturer in each category of insulin.
— goodwinlaw.com, retrieved 2026-08-15
Source
- goodwinlaw.comhttps://www.goodwinlaw.com/en/insights/publications/2025/06/alerts-lifesciences-state-drug-transparency-laws
Open the page on goodwinlaw.com that states this — the page quoted above, at its publisher. Unpaid: we earn nothing from this link and it is not an advertisement.